Abstract
Increasingly, managed care organisations are trying to decide how to get physicians to rationalise their prescribing practices. In this environment, there could be a real role for academic detailing as a means of ensuring independent, cost-effective and safe prescribing, claimed Dr Jerry Avorn from Harvard Medical School in Boston, US, a pioneer in this field. Academic detailing involves exploiting the strengths of the drug industry sales model, using pharmacists to deliver independent advice on prescribing. 1 At the 11th International Conference on Pharmacoepidemiology [ Montréal, Canada; August 1995 ], Dr Avorn and 2 other researchers from the UK and Australia presented models of academic detailing for 3 different healthcare systems.
Additional information
1. Chapman S, et al. Providing independent advice to prescribers: a multinational presentation on ‘academic detailing’. 11th International Conference on Pharmacoepidemiology: 44, 27 Aug 1995
Rights and permissions
About this article
Cite this article
Todd, C. Is there a role for academic detailing in today’s healthcare systems?. Pharmacoecon. Outcomes News 38, 3–5 (1995). https://doi.org/10.1007/BF03309814
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03309814